切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2023, Vol. 17 ›› Issue (04) : 413 -417. doi: 10.3877/cma.j.issn.1674-3946.2023.04.017

论著

RPS21在肝细胞癌中的表达及与免疫浸润和预后的关系研究
王勇, 黄铁模, 于守君()   
  1. 264100 山东烟台,滨州医学院烟台附属医院肝胆胰脾外科
    264001 山东烟台,烟台市奇山医院普外科
    264001 山东烟台,烟台市奇山医院肝胆胰脾外科微创中心
  • 收稿日期:2023-03-07 出版日期:2023-08-26
  • 通信作者: 于守君

The expression of RPS21 in hepatocellular carcinoma and its relationship with immune invasion and prognosis

Yong Wang, Tiemo Huang, Shoujun Yu()   

  1. Department of Hepatobiliary, Pancreatic and spleen Surgery, Pancreatic and Spleen Surgery, Yantai Affiliated Hospital of Binzhou Medical College, Yantai Shandong Province 264100, China
    Department of General Surgery, Yantai Qishan Hospital, Yantai Shandong Province 264001, China
    Minimally Invasive Center of Hepatobiliary, Pancreatic and Spleen Surgery, Yantai Affiliated Hospital of Binzhou Medical College, Yantai Shandong Province 264100, China
  • Received:2023-03-07 Published:2023-08-26
  • Corresponding author: Shoujun Yu
  • Supported by:
    Tantai Science and Technology Plan Project(2022YD086)
引用本文:

王勇, 黄铁模, 于守君. RPS21在肝细胞癌中的表达及与免疫浸润和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2023, 17(04): 413-417.

Yong Wang, Tiemo Huang, Shoujun Yu. The expression of RPS21 in hepatocellular carcinoma and its relationship with immune invasion and prognosis[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(04): 413-417.

目的

研究RPS21在肝细胞癌(HCC)中的表达及与免疫浸润和预后的关系。

方法

回顾性分析2018年8月至2022年12月108例HCC患者资料。通过免疫组织化学法(IHC)和逆转录定量聚合酶链反应(RT-qPCR)法检测HCC组织及相应的癌旁正常组织(距癌组织边缘>5 cm)中RPS21蛋白及mRNA的表达情况。数据应用SPSS 20.0软件处理。采用χ2检验或秩和检验分析RPS21与临床病理特征的关系,利用Kaplan-Meier生存曲线分析RPS21表达与预后的关系,采用Spearman秩相关分析RPS21与免疫浸润水平的相关性。P<0.05为差异有统计学意义。

结果

IHC及RT-qPCR结果显示,HCC组织中RPS21蛋白的阳性表达率显著高于癌旁正常组织(84.3%vs.27.8%,P<0.05),且与癌旁正常组织相比,RPS21mRNA在HCC组织中表达显著上调[(10.1±1.1)vs.(5.5±0.8),P<0.05)]。RPS21高表达与TMN分期及Edmondson分级显著相关(P<0.05)。Spearman秩相关分析显示,HCC中RPS21表达与CD4+肿瘤浸润淋巴细胞(CD4+TILs)、CD8+肿瘤浸润淋巴细胞(CD8+TILs)、Foxp3+调节性T淋巴细胞(Foxp3+Trges)、CD11c+树突状细胞(CD11c+DCs)及CD163+肿瘤相关巨噬细胞(CD163+TAMs)的浸润数目呈正相关(P<0.05)。中位随访时间33个月,通过Kaplan-Meier分析显示,RPS21高表达组的患者累积总生存率及累积无病生存率显著低于RPS21低表达组(65.4%vs.81.5%,61.7%vs.77.8%),差异均有统计学意义(P=0.041、0.044)。

结论

RPS21在HCC组织中呈高表达,且RPS21高表达与HCC的TMN分期、Edmondson分级、免疫浸润及预后密切相关。RPS21可能参与了HCC的发生和发展,同时也可能参免疫调节。

Objective

To study the expression of RPS21 in hepatocellular carcinoma(HCC)and its relationship with immune invasion and prognosis.

Methods

A total of 108 HCC patients from August 2018 to December 2022 were retrospectively included as study subjects. Immunohistochemistry(IHC)and reverse transcriptional quantitative polymerase chain reaction(RT-qPCR)were used to detect the expression of RPS21 protein and mRNA in HCC tissues and corresponding paracancer tissues(>5 cm from the margin of cancer tissue). The data was processed by SPSS 20.0 software. χ2 test or Rank Sum test were used to analyze the relationship between RPS21 and clinicopathologic features,Kaplan-Meier survival curve was used to analyze the relationship between RPS21 expression and prognosis,and Spearman Rank correlation was used to analyze the correlation between RPS21 expression and immune infiltration level. P<0.05 was considered statistically significant.

Results

IHC and RT-qPCR results showed that the positive expression rate of RPS21 protein in HCC tissues was significantly higher than that in paracancer normal tissues(84.3%vs.27.8%,P<0.05),and compared with paracancer normal tissues,The expression of RPS21mRNA was significantly up-regulated in HCC tissues[(10.1±1.1)vs.(5.5±0.8),P<0.05]. The high expression of RPS21 was significantly correlated with TMN stage and Edmondson grade(P<0.05). Spearman rank correlation analysis showed that Expression of RPS21 in HCC is associated with tumor macrotropia in CD4+ tumor infiltrating lymphocytes(CD4+TILs),CD8+TILs,Foxp3+ regulatory T lymphocytes(Foxp3+Trges),CD11c+ dendritic cells(CD11c+DCs),and CD163+ The infiltration number of macrophages(CD163+TAMs)was positively correlated(P<0.05). After a median follow-up of 33 months,Kaplan-Meier analysis showed that the cumulative overall survival rate and disease-free survival rate of the high RPS21 expression group were significantly lower than those of the low RPS21 expression group(65.4%vs.81.5%,61.7%vs.77.8%). The differences were statistically significant(P=0.041,0.044).

Conclusion

RPS21 is highly expressed in HCC tissues,and the high expression of RPS21 is closely related to TMN stage,Edmondson grade,immune invasion and prognosis of HCC. RPS21 may be involved in the occurrence and development of HCC,and may also be involved in immune regulation.

表1 108例HCC患者病理特征
图1 108例HCC组织及癌旁正常组织标本中RPS21蛋白和mRNA的表达情况
表2 108例HCC患者中RPS21表达与临床病理特征的关系[(
x¯
±s),例]
图2 108例HCC患者中CD4+TILs、CD8+TILs、Foxp3+Trges、CD11c+DCs及CD163+TAMs的表达情况
表3 108例HCC患者中RPS21表达与免疫浸润的关系
图3 108例HCC患者中RPS21表达与预后的生存曲线
[1]
沈锋,邹奇飞,范明明,等. 中国腹腔镜肝癌切除术20年发展、问题与对策[J/CD]. 中华普外科手术学杂志(电子版)202115(04):369-373.
[2]
Dinh TTHIseki HMizuno S,et al. Disruption of entire Cables2 locus leads to embryonic lethality by diminished Rps21 gene expression and enhanced p53 pathway[J]. Elife202110:e50346.
[3]
Liang ZMou QPan Z,et al. Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer:RPL22L1 and RPS21[J]. Med Oncol201936(6):56.
[4]
Wang TWang ZYZeng LY,et al. Down-Regulation of Ribosomal Protein RPS21 Inhibits Invasive Behavior of Osteosarcoma Cells Through the Inactivation of MAPK Pathway[J]. Cancer Manag Res202012:4949-4955.
[5]
Deng YZhao HYe L,et al. Correlations Between the Characteristics of Alternative Splicing Events,Prognosis,and the Immune Microenvironment in Breast Cancer[J]. Front Genet202112:686298.
[6]
施婷婷,刘振球,樊虹,等. 2005-2016年中国肝癌发病趋势分析[J]. 中华流行病学杂志202243(03):330-335.
[7]
何凤蝶,王秋童,胡亚男,等. 中国人群肝癌发病危险因素病例对照研究的meta分析[J]. 现代预防医学202249(23):4230-4240.
[8]
Ren ZMa XDuan Z,et al. Diagnosis,Therapy,and Prognosis for Hepatocellular Carcinoma[J]. Anal Cell Pathol(Amst)20202020:8157406.
[9]
叶于富,陈伟,白雪莉. 中国腹腔镜肝癌手术20年演变历程与成就[J/CD]. 中华普外科手术学杂志(电子版)202115(04):363-368.
[10]
袁飞,王树斌. 核糖体蛋白与恶性肿瘤治疗研究进展[J/CD]. 肿瘤代谢与营养电子杂志20196(01):116-119.
[11]
Garcia EL. Allele-specific alternative splicing of Drosophila Ribosomal protein S21 suppresses a lethal mutation in the Phosphorylated adaptor for RNA export(Phax)gene[J]. G3(Bethesda)202212(9):jkac195.
[12]
Sawyer JKKabiri ZMontague RA,et al. Exploiting codon usage identifies intensity-specific modifiers of Ras/MAPK signaling in vivo[J]. PLoS Genet202016(12):e1009228.
[13]
Xu YWei ZFeng M,et al. Tumor-infiltrated activated B cells suppress liver metastasis of colorectal cancers[J]. Cell Rep202240(9):111295.
[1] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[2] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[3] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[4] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[5] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[6] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[7] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[8] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[9] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[10] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[11] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[12] 曾明芬, 王艳. 急性胰腺炎合并脂肪肝患者CT 与彩色多普勒超声诊断参数与其病情和预后的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 531-535.
[13] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[14] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[15] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
阅读次数
全文


摘要